Summary

Persistence Market Research has recently released a comprehensive report on the global Autoimmune Disease Testing Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Autoimmune Disease Testing Market Size (2025E): US$ 6.6 Bn
• Projected Market Value (2032F): US$ 13.4 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 10.8%

Autoimmune Disease Testing Market - Report Scope:

The autoimmune disease testing market encompasses a broad range of diagnostic tools, including instruments, reagents, and consumables used to detect and monitor autoimmune disorders. These tests play a critical role in identifying conditions such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and type 1 diabetes. The market is driven by increasing prevalence of autoimmune diseases, advancements in diagnostic technologies, and growing awareness regarding early disease detection. The expansion of healthcare infrastructure and rising demand for accurate and rapid diagnostic solutions are further supporting market growth.

Market Growth Drivers:

Several key factors are fueling the growth of the global autoimmune disease testing market. The rising incidence and prevalence of autoimmune disorders worldwide have significantly increased the demand for early and accurate diagnostic testing. Growing awareness among patients and healthcare providers regarding the importance of early diagnosis and disease management is also contributing to market expansion. Technological advancements in diagnostic methods, including improved sensitivity and specificity of autoantibody and antinuclear antibody tests, are enhancing testing efficiency. Additionally, increased healthcare expenditure and the expansion of diagnostic laboratory networks are further accelerating market growth.

Market Restraints:

Despite its promising growth potential, the autoimmune disease testing market faces several challenges. High costs associated with advanced diagnostic tests and instruments may limit accessibility, particularly in developing regions. Variability in test accuracy and the possibility of false-positive or false-negative results can impact clinical decision-making and patient outcomes. Furthermore, lack of skilled professionals and limited awareness in certain regions may hinder the adoption of advanced diagnostic technologies, thereby restraining market growth.

Market Opportunities:

The autoimmune disease testing market offers significant growth opportunities driven by continuous advancements in diagnostic technologies and personalized medicine. The development of novel biomarkers and multiplex testing platforms is expected to improve diagnostic accuracy and efficiency. Increasing investments in research and development, along with collaborations between diagnostic companies and research institutions, are likely to create new growth avenues. Emerging markets in Asia-Pacific and Latin America present untapped potential due to improving healthcare infrastructure and rising awareness. Additionally, the integration of automation and digital diagnostics is expected to enhance laboratory productivity and expand market opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the global autoimmune disease testing market's growth?
• Which regions and market segments are experiencing the highest demand for autoimmune disease testing?
• How are advancements in diagnostic technologies influencing market dynamics?
• Who are the key players in the autoimmune disease testing market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future projections for the global autoimmune disease testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the global autoimmune disease testing market are focusing on technological innovation, strategic partnerships, and product portfolio expansion to strengthen their market position. These players are investing heavily in research and development to enhance diagnostic accuracy and develop advanced testing solutions. Collaborations with healthcare providers and diagnostic laboratories are helping companies expand their market reach. Additionally, emphasis on automation, high-throughput testing, and cost-effective solutions is enabling companies to gain a competitive advantage in the evolving market landscape.

Companies Covered in This Report:

• Abbott Laboratories
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers
• Bio-Rad Laboratories
• Beckman Coulter (Danaher Corporation)
• Quest Diagnosticss
• PerkinElmer, Inc.
• bioMérieux
• Werfen (Inova Diagnostics)
• Ortho Clinical Diagnostics
• Trinity Biotech
• EUROIMMUN (A PerkinElmer Company)
• Others

Market Segmentation

By Product

• Instruments
• Reagents and Consumables

By Disease Type

• Systemic autoimmune disease
• Localized autoimmune disease

By Test Type

• Antinuclear antibody tests
• Autoantibody tests
• C-reactive protein (CRP)
• Complete blood count (CBC)
• Urinalysis
• Others

By End-user

• Hospitals and Clinics
• Diagnostic Laboratories
• Research Laboratories
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Autoimmune Disease Testing Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Price Analysis, 2024A
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Autoimmune Disease Testing Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.3. Global Autoimmune Disease Testing Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
5.3.3.1. Instruments
5.3.3.2. Reagents and Consumables
5.3.4. Market Attractiveness Analysis: Product
5.4. Global Autoimmune Disease Testing Market Outlook: Disease Type
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019-2024
5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
5.4.3.1. Systemic autoimmune disease
5.4.3.2. Localized autoimmune disease
5.4.3.3. Market Attractiveness Analysis: Disease Type
5.5. Global Autoimmune Disease Testing Market Outlook: Test Type
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2024
5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
5.5.3.1. Antinuclear antibody tests
5.5.3.2. Autoantibody tests
5.5.3.3. C-reactive protein (CRP)
5.5.3.4. Complete blood count (CBC)
5.5.3.5. Urinalysis
5.5.3.6. Others
5.5.4. Market Attractiveness Analysis: Test Type
5.6. Global Autoimmune Disease Testing Market Outlook: End User
5.6.1. Introduction / Key Findings
5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
5.6.3.1. Hospitals and Clinics
5.6.3.2. Diagnostic Laboratories
5.6.3.3. Research Laboratories
5.6.3.4. Others
5.6.4. Market Attractiveness Analysis: End User
6. Global Autoimmune Disease Testing Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Autoimmune Disease Testing Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Disease Type
7.2.4. By Test Type
7.2.5. By End User
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
7.4.1. Instruments
7.4.2. Reagents and Consumables
7.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
7.5.1. Systemic autoimmune disease
7.5.2. Localized autoimmune disease
7.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
7.6.1. Antinuclear antibody tests
7.6.2. Autoantibody tests
7.6.3. C-reactive protein (CRP)
7.6.4. Complete blood count (CBC)
7.6.5. Urinalysis
7.6.6. Others
7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
7.7.1. Hospitals and Clinics
7.7.2. Diagnostic Laboratories
7.7.3. Research Laboratories
7.7.4. Others
7.8. Market Attractiveness Analysis
8. Europe Autoimmune Disease Testing Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Disease Type
8.2.4. By Test Type
8.2.5. By End User
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
8.4.1. Instruments
8.4.2. Reagents and Consumables
8.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
8.5.1. Systemic autoimmune disease
8.5.2. Localized autoimmune disease
8.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
8.6.1. Antinuclear antibody tests
8.6.2. Autoantibody tests
8.6.3. C-reactive protein (CRP)
8.6.4. Complete blood count (CBC)
8.6.5. Urinalysis
8.6.6. Others
8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
8.7.1. Hospitals and Clinics
8.7.2. Diagnostic Laboratories
8.7.3. Research Laboratories
8.7.4. Others
8.8. Market Attractiveness Analysis
9. East Asia Autoimmune Disease Testing Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Disease Type
9.2.4. By Test Type
9.2.5. By End User
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
9.4.1. Instruments
9.4.2. Reagents and Consumables
9.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
9.5.1. Systemic autoimmune disease
9.5.2. Localized autoimmune disease
9.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
9.6.1. Antinuclear antibody tests
9.6.2. Autoantibody tests
9.6.3. C-reactive protein (CRP)
9.6.4. Complete blood count (CBC)
9.6.5. Urinalysis
9.6.6. Others
9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
9.7.1. Hospitals and Clinics
9.7.2. Diagnostic Laboratories
9.7.3. Research Laboratories
9.7.4. Others
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Autoimmune Disease Testing Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Disease Type
10.2.4. By Test Type
10.2.5. By End User
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
10.4.1. Instruments
10.4.2. Reagents and Consumables
10.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
10.5.1. Systemic autoimmune disease
10.5.2. Localized autoimmune disease
10.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
10.6.1. Antinuclear antibody tests
10.6.2. Autoantibody tests
10.6.3. C-reactive protein (CRP)
10.6.4. Complete blood count (CBC)
10.6.5. Urinalysis
10.6.6. Others
10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
10.7.1. Hospitals and Clinics
10.7.2. Diagnostic Laboratories
10.7.3. Research Laboratories
10.7.4. Others
10.8. Market Attractiveness Analysis
11. Latin America Autoimmune Disease Testing Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Disease Type
11.2.4. By Test Type
11.2.5. By End User
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
11.4.1. Instruments
11.4.2. Reagents and Consumables
11.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
11.5.1. Systemic autoimmune disease
11.5.2. Localized autoimmune disease
11.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
11.6.1. Antinuclear antibody tests
11.6.2. Autoantibody tests
11.6.3. C-reactive protein (CRP)
11.6.4. Complete blood count (CBC)
11.6.5. Urinalysis
11.6.6. Others
11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
11.7.1. Hospitals and Clinics
11.7.2. Diagnostic Laboratories
11.7.3. Research Laboratories
11.7.4. Others
11.8. Market Attractiveness Analysis
12. Middle East & Africa Autoimmune Disease Testing Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product
12.2.3. By Disease Type
12.2.4. By Test Type
12.2.5. By End User
12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
12.4.1. Instruments
12.4.2. Reagents and Consumables
12.5. Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
12.5.1. Systemic autoimmune disease
12.5.2. Localized autoimmune disease
12.6. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
12.6.1. Antinuclear antibody tests
12.6.2. Autoantibody tests
12.6.3. C-reactive protein (CRP)
12.6.4. Complete blood count (CBC)
12.6.5. Urinalysis
12.6.6. Others
12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
12.7.1. Hospitals and Clinics
12.7.2. Diagnostic Laboratories
12.7.3. Research Laboratories
12.7.4. Others
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Abbott Laboratories
13.3.1.1. Overview
13.3.1.2. Segments and Product
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Thermo Fisher Scientific
13.3.3. F. Hoffmann-La Roche Ltd
13.3.4. Siemens Healthineers
13.3.5. Bio-Rad Laboratories
13.3.6. Beckman Coulter (Danaher Corporation)
13.3.7. Quest Diagnostics
13.3.8. PerkinElmer, Inc.
13.3.9. bioMérieux
13.3.10. Werfen (Inova Diagnostics)
13.3.11. Ortho Clinical Diagnostics
13.3.12. Trinity Biotech
13.3.13. EUROIMMUN (A PerkinElmer Company)
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations